Bioabsorbable Magnesium Alloy for Orthopedic Implants and Staged Absorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing bioabsorbable magnesium alloys face challenges in controlling their degradation rate in physiological environments, leading to premature loss of mechanical integrity, hydrogen gas generation, and poor osseointegration, while slow degradation results in prolonged implant presence.
Innovation Solution
A bioabsorbable magnesium alloy with controlled multi-phase absorption profile, comprising specific amounts of zinc, calcium, and optionally manganese, forming a protective oxide layer and tailored microstructure to achieve an initial minimal degradation period, followed by a steady-state phase and accelerated absorption phase.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If magnesium alloy is used for orthopedic implants, then biocompatibility and mechanical properties are improved, but degradation rate cannot be controlled leading to premature loss of mechanical integrity
Solution Approach 1:
The patent modifies the alloy composition parameters by incorporating specific amounts of zinc (0.5-4 wt%), calcium (0.2-1.0 wt%), and a third alloying element (up to 1.0 wt%) to control the degradation rate. This parameter change enables the alloy to maintain mechanical integrity while achieving controlled bioabsorption matching bone healing rates.
Solution Approach 2:
The patent creates a composite microstructure containing multiple phases including Mg2Ca intermetallic phase, ternary intermetallic phases, and remaining magnesium matrix. This composite structure provides both the necessary mechanical strength and controlled degradation behavior for orthopedic implants.
2Duration of action of stationary object
If degradation rate is increased to accelerate absorption, then implant removal is eliminated, but mechanical integrity is lost prematurely
Solution Approach 1:
The patent adjusts alloying element concentrations and microstructural phase distributions to achieve an optimal balance between strength and degradation rate. The specific composition ranges and phase morphology control ensure sufficient mechanical strength during critical healing periods while enabling timely absorption.
Solution Approach 2:
The patent achieves dynamic control of degradation through a multi-phase absorption profile with distinct stages: initial minimal degradation phase, steady-state phase, and accelerated absorption phase. This dynamic behavior allows the implant to maintain strength when needed and absorb when appropriate.
3Reliability
If alloying elements are added to control corrosion, then degradation rate is improved, but microstructure complexity increases
Solution Approach 1:
The patent optimizes the concentration parameters of alloying elements (zinc: 0.5-4 wt%, calcium: 0.2-1.0 wt%, third element: up to 1.0 wt%) to achieve desired corrosion resistance without excessive microstructural complexity. The controlled phase formation through parameter optimization simplifies the microstructure while maintaining reliability.
4Reliability
If protective oxide layer forms on alloy surface, then corrosion resistance is improved, but initial degradation is reduced
Solution Approach 1:
The patent modifies alloy composition parameters to control oxide layer formation and properties. The specific alloying elements and their concentrations are optimized to achieve an oxide layer that provides sufficient protection while allowing controlled degradation through the multi-phase absorption profile.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The alloy maintains mechanical integrity during critical healing phases, ensuring gradual absorption matching bone healing rates, reducing complications like infections, and providing a broader application range for orthopedic and maxillofacial implants.
Implementation Method 1
The alloy forms a protective oxide layer when exposed to physiological conditions
Implementation Method 2
The alloy exhibits a controlled, multi-phase absorption profile when exposed to physiological conditions
Data Source
AI summary
A bioabsorbable magnesium alloy for use in an orthopedic implant comprises magnesium, zinc in an amount of 0.5-4 weight percent, calcium in an amount of 0.1-1.5 weight percent, and manganese in an amount of up to 1.5 weight percent. The alloy exhibits a controlled, multi-phase absorption profile when exposed to physiological conditions, including an initial period of minimal degradation, followed by a steady-state phase, and concluding with an accelerated absorption phase. A method of manufacturing the alloy includes casting, solution treating, and extruding. An orthopedic implant device formed from the alloy comprises a body that exhibits the controlled, multi-phase absorption profile when implanted.